140 related articles for article (PubMed ID: 3100307)
1. Combined treatment with cholestyramine and nicotinic acid in heterozygous familial hypercholesterolaemia: effects on biliary lipid composition.
Angelin B; Eriksson M; Einarsson K
Eur J Clin Invest; 1986 Oct; 16(5):391-6. PubMed ID: 3100307
[TBL] [Abstract][Full Text] [Related]
2. Superiority of partial ileal bypass over cholestyramine reducing cholesterol in familial hypercholesterolaemia.
Spengel FA; Jadhav A; Duffield RG; Wood CB; Thompson GR
Lancet; 1981 Oct; 2(8250):768-70. PubMed ID: 6116902
[TBL] [Abstract][Full Text] [Related]
3. Effects of combination cholestyramine-neomycin treatment on plasma lipoprotein concentrations in type II hyperlipoproteinemia.
Hoeg JM; Maher MB; Bailey KR; Zech LA; Gregg RE; Sprecher DL; Brewer HB
Am J Cardiol; 1985 May; 55(11):1282-6. PubMed ID: 3887883
[TBL] [Abstract][Full Text] [Related]
4. Long-term follow-up of children with familial hypercholesterolaemia treated with cholestyramine.
West RJ; Lloyd JK; Leonard JV
Lancet; 1980 Oct; 2(8200):873-5. PubMed ID: 6107543
[TBL] [Abstract][Full Text] [Related]
5. Cholestyramine in type IIa hyperlipoproteinemia. Is low-dose treatment feasible?
Angelin B; Einarsson K
Atherosclerosis; 1981; 38(1-2):33-8. PubMed ID: 7470203
[TBL] [Abstract][Full Text] [Related]
6. Treatment of heterozygous familial hypercholesterolemia with lipid-lowering drugs.
Illingworth DR; Bacon S
Arteriosclerosis; 1989; 9(1 Suppl):I121-34. PubMed ID: 2492189
[TBL] [Abstract][Full Text] [Related]
7. Combined drug therapy for familial hypercholesterolemia.
Packard CJ; Stewart JM; Morgan HG; Lorimer AR; Shepherd J
Artery; 1980; 7(4):281-9. PubMed ID: 7213018
[TBL] [Abstract][Full Text] [Related]
8. Effects of lovastatin alone and in combination with cholestyramine on serum lipids and apolipoproteins in heterozygotes for familial hypercholesterolemia.
Leren TP; Hjermann I; Berg K; Leren P; Foss OP; Viksmoen L
Atherosclerosis; 1988 Oct; 73(2-3):135-41. PubMed ID: 3056429
[TBL] [Abstract][Full Text] [Related]
9. Treatment of familial hypercholesterolemia with drugs in children.
Stein EA
Arteriosclerosis; 1989; 9(1 Suppl):I145-51. PubMed ID: 2912428
[TBL] [Abstract][Full Text] [Related]
10. Reduction of serum cholesterol in heterozygous patients with familial hypercholesterolemia. Additive effects of compactin and cholestyramine.
Mabuchi H; Sakai T; Sakai Y; Yoshimura A; Watanabe A; Wakasugi T; Koizumi J; Takeda R
N Engl J Med; 1983 Mar; 308(11):609-13. PubMed ID: 6828091
[TBL] [Abstract][Full Text] [Related]
11. Effect of pravastatin, an HMG CoA reductase inhibitor, and cholestyramine, a bile acid sequestrant, on lipoprotein particles defined by their apolipoprotein composition.
Bard JM; Parra HJ; Douste-Blazy P; Fruchart JC
Metabolism; 1990 Mar; 39(3):269-73. PubMed ID: 2106607
[TBL] [Abstract][Full Text] [Related]
12. Effects of simvastatin and cholestyramine on bile lipid composition and gall bladder motility in patients with hypercholesterolaemia.
Smit JW; Van Erpecum KJ; Portincasa P; Renooij W; Erkelens DW; Van Berge-Henegouwen GP
Gut; 1995 Nov; 37(5):654-9. PubMed ID: 8549941
[TBL] [Abstract][Full Text] [Related]
13. Cholestyramine treatment reduces postprandial but not fasting serum bile acid levels in humans.
Angelin B; Björkhem I; Einarsson K; Ewerth S
Gastroenterology; 1982 Nov; 83(5):1097-101. PubMed ID: 7117793
[TBL] [Abstract][Full Text] [Related]
14. Combination drug therapy with HMG CoA reductase inhibitors and bile acid sequestrants for hypercholesterolemia.
Erkelens DW
Cardiology; 1990; 77 Suppl 4():33-8. PubMed ID: 2073670
[TBL] [Abstract][Full Text] [Related]
15. Long-term effects of bezafibrate and of a bezafibrate and cholestyramine combination on lipids and lipoprotein lipids in type IIa hypercholesterolaemic patients.
Sommariva D; Tirrito M; Bonfiglioli D; Pogliaghi I; Branchi A; Cabrini E
Int J Clin Pharmacol Res; 1986; 6(3):249-53. PubMed ID: 3744628
[TBL] [Abstract][Full Text] [Related]
16. Contrasting effects of lovastatin and cholestyramine on low-density lipoprotein cholesterol and 24-hour urinary mevalonate excretion in patients with heterozygous familial hypercholesterolemia.
Pappu AS; Illingworth DR
J Lab Clin Med; 1989 Nov; 114(5):554-62. PubMed ID: 2809398
[TBL] [Abstract][Full Text] [Related]
17. Cholestyramine plus pectin in treatment of patients with familial hypercholesterolemia.
Schwandt P; Richter WO; Weisweiler P; Neureuther G
Atherosclerosis; 1982 Sep; 44(3):379-83. PubMed ID: 7150399
[TBL] [Abstract][Full Text] [Related]
18. Combination treatment with cholestyramine and bezafibrate for heterozygous familial hypercholesterolaemia.
Curtis LD; Dickson AC; Ling KL; Betteridge J
BMJ; 1988 Jul; 297(6642):173-5. PubMed ID: 3044508
[TBL] [Abstract][Full Text] [Related]
19. The effect of combined fenofibrate and cholestyramine therapy on low-density lipoprotein kinetics in familial hypercholesterolemia patients.
Malmendier CL; Delcroix C; Lontie JF
Clin Chim Acta; 1987 Jan; 162(2):221-7. PubMed ID: 3829426
[TBL] [Abstract][Full Text] [Related]
20. Increased turnover of very low density lipoprotein triglyceride during treatment with cholestyramine in familial hypercholesterolaemia.
Angelin B; Leijd B; Hultcrantz R; Einarsson K
J Intern Med; 1990 Mar; 227(3):201-6. PubMed ID: 2313228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
